Northwest Biotherapeutics, Inc Logo Image

Northwest Biotherapeutics, Inc

Northwest Biotherapeutics, Inc Banner Image

Most Recent Annual Report

2015 Form 10K

Northwest Biotherapeutics, Inc

Northwest Biotherapeutics, Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



About Northwest Biotherapeutics, Inc

11-50 Employees
Based in Bethesda, Maryland

Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. It is involved in the development of DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.

Ticker:
NWBO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol